Evidence map›Paper›PMID 22365614›Full record

ReviewCurrent opinion in immunology2012

The symphony of the ninth: the development and function of Th9 cells.

Rukhsana Jabeen, Mark H Kaplan

Abstract readReview
In one paragraph

Review in Current opinion in immunology, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 44 papers.

0numbers the graph read from it
0cells of the map it votes in
44citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

44 citing papers in PubMed.

  1. Article
  2. Th9 cells provide protective TB immunity.Frontiers in immunology · 2025
    Article
  3. Review
  4. Review
  5. Review
  6. Review
  7. Review
  8. Review
  9. Gut CD4Nature immunology · 2021
    Article
  10. Article
  11. Article
  12. Review
  13. Review
  14. Resolution of allergic asthma.Seminars in immunopathology · 2019
    Review
  15. The cytokine environment influence on human skin-derived T cells.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2019
    Article
  16. Review
  17. Review
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Rukhsana JabeenDepartment of Pediatrics, Herman B Wells Center for Pediatric Research, Indianapolis, IN 46202, United States.
Mark H Kaplan

Funding

The role of PU.1 in T helper cell heterogeneityR01AI057459 · NIAID · INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS · PI KAPLAN, MARK H · 2005 to 2025
$8.2M
NIAID NIH HHS AI057459NIAID NIH HHS R01 AI057459
6 · The paper itself

Abstract

CD4+ T helper cells are obligate regulators of inflammatory disease. An expanding cadre of T helper (Th) subsets, specialized for promoting particular types of inflammation, function through the secretion of a restricted set of cytokines. The latest addition to the list of subsets is the Th9 cell that secretes IL-9 as a signature cytokine and contributes to several classes of inflammatory disease. In this review we focus on recent advances in understanding the development of Th9 cells, and how Th9 cells contribute to the orchestration of disease.

Indexed as

AnimalsCell DifferentiationHumansInterleukin-9Signal TransductionT-Lymphocytes, Helper-InducerTranscription, GeneticInterleukin-9

Identifiers

PMID22365614
PMCPMC3368035

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.